GRANULICATELLA INFECTION

GRANULICATELLA INFECTION was reported 42 times

GRANULICATELLA INFECTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD33-directed Immunoconjugate [EPC] 11 0.0030
1 Actinomycin [EPC] 1 0.0005
2 Antiparasitic [EPC] 2 0.0004
3 Pediculicide [EPC] 2 0.0004
4 Bile Acid [EPC] 9 0.0004
5 Selective T Cell Costimulation Blocker [EPC] 1 0.0002
6 Lipopeptide Antibacterial [EPC] 2 0.0002
7 Echinocandin Antifungal [EPC] 1 0.0001
8 Antifibrinolytic Agent [EPC] 1 0.0001
9 Antimalarial [EPC] 1 0.0001
10 Antiprotozoal [EPC] 1 0.0001
11 Alkylating Drug [EPC] 22 0.0001
12 Serotonin-3 Receptor Antagonist [EPC] 9 0.0001
13 Calcineurin Inhibitor Immunosuppressant [EPC] 8 0.0001
14 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0001
15 Azole Antifungal [EPC] 9 0.0001
16 Nucleoside Metabolic Inhibitor [EPC] 15 0.0001
17 Human Immunoglobulin G [EPC] 1 0.0000
18 Glycopeptide Antibacterial [EPC] 3 0.0000
19 Topoisomerase Inhibitor [EPC] 3 0.0000
20 CD20-directed Cytolytic Antibody [EPC] 11 0.0000
21 Folate Analog Metabolic Inhibitor [EPC] 15 0.0000
22 Corticosteroid [EPC] 26 0.0000
23 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
24 Proteasome Inhibitor [EPC] 1 0.0000
25 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
26 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
27 Leukocyte Growth Factor [EPC] 1 0.0000
28 Janus Kinase Inhibitor [EPC] 1 0.0000
29 Kinase Inhibitor [EPC] 3 0.0000
30 Platinum-based Drug [EPC] 1 0.0000
31 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000